In patients with simple MCI or AD, sMRI was strongly associated with measures of cognitive function, and it showed more prediction accuracy in the progression of aMCI to AD than CSF tau, which were considered to be the biomarker for AD diagnosis for a long time (Brier et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.